Xenetic Biosciences Ownership 2024 | Who Owns Xenetic Biosciences Now?

Overview Forecast RevenueFinancials Chart

Institutional Ownership

3.80%

Insider Ownership

19.03%

Retail Ownership

77.17%

Institutional Holders

18.00

Xenetic Biosciences Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
WELLS FARGO & COMPANY/MN	-	-	-	-105	-100.00%	-	Jun 30, 2023
NORTHERN TRUST CORP	-	-	-	-17,760	-100.00%	-	Jun 30, 2023
STATE STREET CORP	-	-	-	-34,668	-100.00%	-	Jun 30, 2023
VANGUARD GROUP INC	-	-	-	-96,982	-100.00%	-	Jun 30, 2023
FMR LLC	-	-	-	-217	-100.00%	-	Jun 30, 2023
MORGAN STANLEY	-	-	-	-2,952	-100.00%	-	Jun 30, 2023
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-99,507	-100.00%	-	Jun 30, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-91,545	-100.00%	-	Jun 30, 2023
CITADEL ADVISORS LLC	-	-	-	-16,366	-100.00%	-	Jun 30, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-20,224	-100.00%	-	Jun 30, 2023
HRT FINANCIAL LP	-	-	-	-37,473	-100.00%	-	Jun 30, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-11,354	-100.00%	-	Jun 30, 2023
NEWSQUARE CAPITAL LLC	-	-	-	-260	-100.00%	-	Jun 30, 2023
ERGOTELES LLC	-	-	-	-12,773	-100.00%	-	Jun 30, 2023
STEWARD PARTNERS INVESTMENT ADVISORY, LLC	-	-	-	-19,000	-100.00%	-	Jun 30, 2023
GREAT VALLEY ADVISOR GROUP, INC.	-	-	-	-10,600	-100.00%	-	Jun 30, 2023
JTC EMPLOYER SOLUTIONS TRUSTEE LTD	-	-	-	-26,991	-100.00%	-	Jun 30, 2023

Xenetic Biosciences's largest institutional shareholder is WELLS FARGO & COMPANY/MN, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
WELLS FARGO & COMPANY/MN	-	-	-	-105	-100.00%	-	Jun 30, 2023
NORTHERN TRUST CORP	-	-	-	-17,760	-100.00%	-	Jun 30, 2023
STATE STREET CORP	-	-	-	-34,668	-100.00%	-	Jun 30, 2023
VANGUARD GROUP INC	-	-	-	-96,982	-100.00%	-	Jun 30, 2023
FMR LLC	-	-	-	-217	-100.00%	-	Jun 30, 2023
MORGAN STANLEY	-	-	-	-2,952	-100.00%	-	Jun 30, 2023
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-99,507	-100.00%	-	Jun 30, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-91,545	-100.00%	-	Jun 30, 2023
CITADEL ADVISORS LLC	-	-	-	-16,366	-100.00%	-	Jun 30, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-20,224	-100.00%	-	Jun 30, 2023
HRT FINANCIAL LP	-	-	-	-37,473	-100.00%	-	Jun 30, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-11,354	-100.00%	-	Jun 30, 2023
NEWSQUARE CAPITAL LLC	-	-	-	-260	-100.00%	-	Jun 30, 2023
ERGOTELES LLC	-	-	-	-12,773	-100.00%	-	Jun 30, 2023
STEWARD PARTNERS INVESTMENT ADVISORY, LLC	-	-	-	-19,000	-100.00%	-	Jun 30, 2023
GREAT VALLEY ADVISOR GROUP, INC.	-	-	-	-10,600	-100.00%	-	Jun 30, 2023
JTC EMPLOYER SOLUTIONS TRUSTEE LTD	-	-	-	-26,991	-100.00%	-	Jun 30, 2023

The largest Xenetic Biosciences shareholder by % of total assets is WELLS FARGO & COMPANY/MN. The company owns 0.00 shares of Xenetic Biosciences (XBIO), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
WELLS FARGO & COMPANY/MN	-	-	-	-105	-100.00%	-	Jun 30, 2023
FMR LLC	-	-	-	-217	-100.00%	-	Jun 30, 2023
NEWSQUARE CAPITAL LLC	-	-	-	-260	-100.00%	-	Jun 30, 2023
MORGAN STANLEY	-	-	-	-2,952	-100.00%	-	Jun 30, 2023
GREAT VALLEY ADVISOR GROUP, INC.	-	-	-	-10,600	-100.00%	-	Jun 30, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-11,354	-100.00%	-	Jun 30, 2023
ERGOTELES LLC	-	-	-	-12,773	-100.00%	-	Jun 30, 2023
CITADEL ADVISORS LLC	-	-	-	-16,366	-100.00%	-	Jun 30, 2023
NORTHERN TRUST CORP	-	-	-	-17,760	-100.00%	-	Jun 30, 2023
STEWARD PARTNERS INVESTMENT ADVISORY, LLC	-	-	-	-19,000	-100.00%	-	Jun 30, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-20,224	-100.00%	-	Jun 30, 2023
JTC EMPLOYER SOLUTIONS TRUSTEE LTD	-	-	-	-26,991	-100.00%	-	Jun 30, 2023
STATE STREET CORP	-	-	-	-34,668	-100.00%	-	Jun 30, 2023
HRT FINANCIAL LP	-	-	-	-37,473	-100.00%	-	Jun 30, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-91,545	-100.00%	-	Jun 30, 2023
VANGUARD GROUP INC	-	-	-	-96,982	-100.00%	-	Jun 30, 2023
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-99,507	-100.00%	-	Jun 30, 2023

As of Jun 30 2023, Xenetic Biosciences's largest institutional buyer is WELLS FARGO & COMPANY/MN. The company purchased -0.10K stocks of XBIO, valued at -.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-99,507	-100.00%	-	Jun 30, 2023
VANGUARD GROUP INC	-	-	-	-96,982	-100.00%	-	Jun 30, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-91,545	-100.00%	-	Jun 30, 2023
HRT FINANCIAL LP	-	-	-	-37,473	-100.00%	-	Jun 30, 2023
STATE STREET CORP	-	-	-	-34,668	-100.00%	-	Jun 30, 2023
JTC EMPLOYER SOLUTIONS TRUSTEE LTD	-	-	-	-26,991	-100.00%	-	Jun 30, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-20,224	-100.00%	-	Jun 30, 2023
STEWARD PARTNERS INVESTMENT ADVISORY, LLC	-	-	-	-19,000	-100.00%	-	Jun 30, 2023
NORTHERN TRUST CORP	-	-	-	-17,760	-100.00%	-	Jun 30, 2023
CITADEL ADVISORS LLC	-	-	-	-16,366	-100.00%	-	Jun 30, 2023
ERGOTELES LLC	-	-	-	-12,773	-100.00%	-	Jun 30, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-11,354	-100.00%	-	Jun 30, 2023
GREAT VALLEY ADVISOR GROUP, INC.	-	-	-	-10,600	-100.00%	-	Jun 30, 2023
MORGAN STANLEY	-	-	-	-2,952	-100.00%	-	Jun 30, 2023
NEWSQUARE CAPITAL LLC	-	-	-	-260	-100.00%	-	Jun 30, 2023
FMR LLC	-	-	-	-217	-100.00%	-	Jun 30, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-105	-100.00%	-	Jun 30, 2023

As of Jun 30 2023, Xenetic Biosciences's biggest institutional seller is RENAISSANCE TECHNOLOGIES LLC. The company sold -99.51K shares of XBIO, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-99,507	-100.00%	-	Jun 30, 2023
VANGUARD GROUP INC	-	-	-	-96,982	-100.00%	-	Jun 30, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-91,545	-100.00%	-	Jun 30, 2023
HRT FINANCIAL LP	-	-	-	-37,473	-100.00%	-	Jun 30, 2023
STATE STREET CORP	-	-	-	-34,668	-100.00%	-	Jun 30, 2023
JTC EMPLOYER SOLUTIONS TRUSTEE LTD	-	-	-	-26,991	-100.00%	-	Jun 30, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-20,224	-100.00%	-	Jun 30, 2023
STEWARD PARTNERS INVESTMENT ADVISORY, LLC	-	-	-	-19,000	-100.00%	-	Jun 30, 2023
NORTHERN TRUST CORP	-	-	-	-17,760	-100.00%	-	Jun 30, 2023
CITADEL ADVISORS LLC	-	-	-	-16,366	-100.00%	-	Jun 30, 2023
ERGOTELES LLC	-	-	-	-12,773	-100.00%	-	Jun 30, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-11,354	-100.00%	-	Jun 30, 2023
GREAT VALLEY ADVISOR GROUP, INC.	-	-	-	-10,600	-100.00%	-	Jun 30, 2023
MORGAN STANLEY	-	-	-	-2,952	-100.00%	-	Jun 30, 2023
NEWSQUARE CAPITAL LLC	-	-	-	-260	-100.00%	-	Jun 30, 2023
FMR LLC	-	-	-	-217	-100.00%	-	Jun 30, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-105	-100.00%	-	Jun 30, 2023

Xenetic Biosciences's largest sold out institutional shareholder by shares sold is RENAISSANCE TECHNOLOGIES LLC, sold -99.51K shares, valued at -, as of undefined.

Xenetic Biosciences Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
FIDELITY COMMONWEALTH TRUST	0.01%	19,052	-	-	Feb 29, 2024
FIDELITY CONCORD STREET TRUST	0.00%	89,890	-	-	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	96,982	-	-	Mar 31, 2024
Dimensional ETF Trust	0.00%	26,294	-	-	Jan 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	10,774	-39	-0.36%	Feb 29, 2024
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	48,755	-	-	Jan 31, 2024
VANGUARD INDEX FUNDS	0.00%	9,797	-9,797	-50.00%	Mar 31, 2024

Xenetic Biosciences's largest mutual fund holder by % of total assets is "FIDELITY COMMONWEALTH TRUST", owning 19.05K shares, compromising 0.01% of its total assets.

Xenetic Biosciences Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Mar, 23	18	-
31 Dec, 22	18	38.46%
30 Sep, 22	13	8.33%
30 Jun, 22	12	-7.69%
31 Mar, 22	13	-35.00%
31 Dec, 21	20	25.00%
30 Sep, 21	16	45.45%
30 Jun, 21	11	10.00%
31 Mar, 21	10	25.00%
31 Dec, 20	8	60.00%
30 Sep, 20	5	66.67%
30 Jun, 20	3	-25.00%
31 Mar, 20	4	-42.86%
31 Dec, 19	7	16.67%
30 Sep, 19	6	20.00%
30 Jun, 19	5	-

As of 31 Mar 23, 18 institutions are holding Xenetic Biosciences's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Mar, 23	576,596	-16.89%
31 Dec, 22	693,755	-30.09%
30 Sep, 22	992,384	-4.08%
30 Jun, 22	1,034,614	-1.15%
31 Mar, 22	1,046,598	-28.20%
31 Dec, 21	1,457,756	-12.84%
30 Sep, 21	1,672,423	309.68%
30 Jun, 21	408,229	-26.80%
31 Mar, 21	557,660	84.62%
31 Dec, 20	302,056	206.01%
30 Sep, 20	98,707	-50.72%
30 Jun, 20	200,294	-20.44%
31 Mar, 20	251,737	-49.99%
31 Dec, 19	503,350	3.49%
30 Sep, 19	486,382	644.12%
30 Jun, 19	65,363	-

Xenetic Biosciences (XBIO) has 576.60K shares outstanding as of 31 Mar 23, down -16.89% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Mar, 23	3.80%	18.17%
31 Dec, 22	4.57%	10.68%
30 Sep, 22	6.54%	14.06%
30 Jun, 22	6.82%	14.32%
31 Mar, 22	6.90%	7.47%
31 Dec, 21	9.61%	7.90%
30 Sep, 21	11.03%	152.21%
30 Jun, 21	2.69%	6.74%
31 Mar, 21	6.32%	53.91%
31 Dec, 20	3.42%	273.47%
30 Sep, 20	1.12%	21.70%
30 Jun, 20	2.27%	27.88%
31 Mar, 20	2.85%	8.76%
31 Dec, 19	5.71%	18.77%
30 Sep, 19	5.51%	1004.21%
30 Jun, 19	0.74%	-

As of 31 Mar 23, Xenetic Biosciences is held by 3.80% institutional shareholders, representing a 18.17% growth compared to 31 Dec 22.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Mar, 23	4	-60.00%
31 Dec, 22	10	233.33%
30 Sep, 22	3	-40.00%
30 Jun, 22	5	25.00%
31 Mar, 22	4	-63.64%
31 Dec, 21	11	-15.38%
30 Sep, 21	13	160.00%
30 Jun, 21	5	-37.50%
31 Mar, 21	8	33.33%
31 Dec, 20	6	200.00%
30 Sep, 20	2	100.00%
30 Jun, 20	1	-
31 Mar, 20	1	-75.00%
31 Dec, 19	4	-33.33%
30 Sep, 19	6	20.00%
30 Jun, 19	5	-

4 institutional shareholders have increased their position in XBIO stock as of 31 Mar 23 compared to 10 in the previous quarter (a -60.00% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Mar, 23	7	133.33%
31 Dec, 22	3	-
30 Sep, 22	3	50.00%
30 Jun, 22	2	-33.33%
31 Mar, 22	3	-25.00%
31 Dec, 21	4	300.00%
30 Sep, 21	1	-50.00%
30 Jun, 21	2	-
31 Mar, 21	-	-
31 Dec, 20	-	-100.00%
30 Sep, 20	1	-
30 Jun, 20	-	-100.00%
31 Mar, 20	1	-
31 Dec, 19	1	-
30 Sep, 19	-	-
30 Jun, 19	-	-

7 institutional shareholders have reduced their position in XBIO stock as of 31 Mar 23 compared to 3 in the previous quarter (a 133.33% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Mar, 23	18	-	576,596	-16.89%	3.80%	18.17%	4	-60.00%	7	133.33%
31 Dec, 22	18	38.46%	693,755	-30.09%	4.57%	10.68%	10	233.33%	3	-
30 Sep, 22	13	8.33%	992,384	-4.08%	6.54%	14.06%	3	-40.00%	3	50.00%
30 Jun, 22	12	-7.69%	1,034,614	-1.15%	6.82%	14.32%	5	25.00%	2	-33.33%
31 Mar, 22	13	-35.00%	1,046,598	-28.20%	6.90%	7.47%	4	-63.64%	3	-25.00%
31 Dec, 21	20	25.00%	1,457,756	-12.84%	9.61%	7.90%	11	-15.38%	4	300.00%
30 Sep, 21	16	45.45%	1,672,423	309.68%	11.03%	152.21%	13	160.00%	1	-50.00%
30 Jun, 21	11	10.00%	408,229	-26.80%	2.69%	6.74%	5	-37.50%	2	-
31 Mar, 21	10	25.00%	557,660	84.62%	6.32%	53.91%	8	33.33%	-	-
31 Dec, 20	8	60.00%	302,056	206.01%	3.42%	273.47%	6	200.00%	-	-100.00%
30 Sep, 20	5	66.67%	98,707	-50.72%	1.12%	21.70%	2	100.00%	1	-
30 Jun, 20	3	-25.00%	200,294	-20.44%	2.27%	27.88%	1	-	-	-100.00%
31 Mar, 20	4	-42.86%	251,737	-49.99%	2.85%	8.76%	1	-75.00%	1	-
31 Dec, 19	7	16.67%	503,350	3.49%	5.71%	18.77%	4	-33.33%	1	-
30 Sep, 19	6	20.00%	486,382	644.12%	5.51%	1004.21%	6	20.00%	-	-
30 Jun, 19	5	-	65,363	-	0.74%	-	5	-	-	-

Xenetic Biosciences Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Dec 18, 2023	Mizrahy Moshe	director	-		Sell	-	-	-	-

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jun 21, 2024	PARSLOW JAMES F	officer	Interim CEO and CFO	A-Award	Buy	20,000	$3.99	$79.80K	20,000
Dec 18, 2023	Mizrahy Moshe	director	-	A-Award	Buy	2,500	$4.29	$10.72K	2,500
Dec 18, 2023	Mizrahy Moshe	director	-		Sell	-	-	-	-
Dec 13, 2023	Lockshin Curtis	officer	Chief Sciencific Officer	A-Award	Buy	10,000	$3.88	$38.80K	10,000
Dec 13, 2023	EISENBERG JEFFREY F	director, officer	Chief Executive Officer	A-Award	Buy	20,000	$3.88	$77.60K	20,000
Dec 13, 2023	PARSLOW JAMES F	officer	Chief Financial Officer	A-Award	Buy	10,000	$3.88	$38.80K	10,000
Dec 08, 2023	Kornberg Roger D.	director	-	A-Award	Buy	2,500	$4.29	$10.72K	2,500
Dec 08, 2023	Borisenko Grigory G.	director	-	A-Award	Buy	2,500	$4.29	$10.72K	2,500
Dec 08, 2023	Dastoor Firdaus J.	director	-	A-Award	Buy	2,500	$4.29	$10.72K	2,500
Dec 08, 2023	Callaway James Eric	director	-	A-Award	Buy	2,500	$4.29	$10.72K	2,500
Dec 08, 2023	VINOGRADOV ALEXEY ANDREEVICH	director	-	A-Award	Buy	2,500	$4.29	$10.72K	2,500
Dec 08, 2023	Logal Adam	director	-	A-Award	Buy	2,500	$4.29	$10.72K	2,500
Dec 09, 2022	VINOGRADOV ALEXEY ANDREEVICH	director	-	A-Award	Buy	25,000	-	-	25,000
Dec 09, 2022	Logal Adam	director	-	A-Award	Buy	25,000	-	-	25,000
Dec 09, 2022	Kornberg Roger D.	director	-	A-Award	Buy	25,000	-	-	25,000
Dec 09, 2022	Dastoor Firdaus J.	director	-	A-Award	Buy	25,000	-	-	25,000
Dec 09, 2022	Callaway James Eric	director	-	A-Award	Buy	25,000	-	-	25,000
Dec 09, 2022	Borisenko Grigory G.	director	-	A-Award	Buy	25,000	-	-	25,000
Mar 28, 2022	EISENBERG JEFFREY F	officer	Chief Executive Officer	A-Award	Buy	100,000	-	-	100,000
Mar 28, 2022	EISENBERG JEFFREY F	director, officer	Chief Executive Officer	A-Award	Buy	100,000	$1.12	$112.00K	100,000

The last insider sell of Xenetic Biosciences's stock was made by Mizrahy Moshe on Dec 18 2023, selling - shares at - per share (valued at -).

Xenetic Biosciences Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q4 2023	9	-	-
Q4 2022	6	-	-
Q1 2022	3	-	-
Q4 2021	2	-	-
Q1 2021	3	-	-
Q4 2020	2	-	-
Q1 2020	-	1	-
Q4 2019	5	-	-
Q3 2019	-	1	-
Q4 2018	2	-	-
Q4 2017	7	-	-
Q3 2017	-	3	-
Q2 2017	1	-	-
Q4 2016	14	11	127.27%
Q3 2016	-	8	-
Q2 2016	-	1	-
Q3 2015	-	1	-
Q4 2014	-	4	-
Q1 2014	-	4	-

9 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Xenetic Biosciences's insiders, as of Q4 2023.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q4 2023	-	-	-
Q4 2022	-	-	-
Q1 2022	-	-	-
Q4 2021	-	-	-
Q1 2021	-	-	-
Q4 2020	-	-	-
Q1 2020	-	-	-
Q4 2019	-	-	-
Q3 2019	-	-	-
Q4 2018	-	-	-
Q4 2017	-	-	-
Q3 2017	-	-	-
Q2 2017	-	-	-
Q4 2016	-	-	-
Q3 2016	-	-	-
Q2 2016	-	-	-
Q3 2015	-	-	-
Q4 2014	-	-	-
Q1 2014	-	-	-

As of Q4 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Xenetic Biosciences's stocks.

Xenetic Biosciences Peer Ownership

Ticker	Company
ZVSA	ZyVersa Therapeutics, Inc.
GOVX	GeoVax Labs, Inc.
ONCR	Oncorus, Inc.
PHIO	Phio Pharmaceuticals Corp.
REVB	Revelation Biosciences, Inc.
RNAZ	TransCode Therapeutics, Inc.
TNXP	Tonix Pharmaceuticals Holding Corp.
YS	LakeShore Biopharma Co., Ltd
LABP	Landos Biopharma, Inc.
VRAX	Virax Biolabs Group Limited
IMMX	Immix Biopharma, Inc.
CYTO	Altamira Therapeutics Ltd.
SONN	Sonnet BioTherapeutics Holdings, Inc.
DRUG	Bright Minds Biosciences Inc.
ZURA	Zura Bio Limited
ENVB	Enveric Biosciences, Inc.
ATNF	180 Life Sciences Corp.
PALI	Palisade Bio, Inc.

XBIO Ownership FAQ

Who Owns Xenetic Biosciences?

Xenetic Biosciences is owned by institutional shareholders (3.80%), insiders (19.03%), and public (77.17%). The largest institutional shareholder of Xenetic Biosciences is WELLS FARGO & COMPANY/MN (0% of total shares) and the top mutual fund owner is FIDELITY COMMONWEALTH TRUST (0.01% of total shares).

Who are the major institutional shareholders of Xenetic Biosciences?

Xenetic Biosciences's major institutional shareholders are WELLS FARGO & COMPANY/MN, NORTHERN TRUST CORP, STATE STREET CORP, VANGUARD GROUP INC, and FMR LLC. The top five shareholders own together 0% of the company's share outstanding.

How many Xenetic Biosciences shareholders are there?

As of Mar 2023, there are 18 institutional shareholders of Xenetic Biosciences.

What percentage of Xenetic Biosciences is owned by WELLS FARGO & COMPANY/MN?

WELLS FARGO & COMPANY/MN owns 0 shares of Xenetic Biosciences, representing 0% of the company's total shares outstanding, valued at $0 (as of Jun 2023).

What percentage of Xenetic Biosciences is owned by NORTHERN TRUST CORP?

As of Jun 2023, NORTHERN TRUST CORP holds 0 shares of Xenetic Biosciences (XBIO), compromising 0% of the company, valued at $0.

What percentage of Xenetic Biosciences is owned by STATE STREET CORP?

STATE STREET CORP is the third largest holder of Xenetic Biosciences. The company owns 0 of the company's shares outstanding (worth $0).